"10.1371_journal.pone.0044943","plos one","2012-09-12T00:00:00Z","Emily K Forbes; Simone C de Cassan; David Llewellyn; Sumi Biswas; Anna L Goodman; Matthew G Cottingham; Carole A Long; Richard J Pleass; Adrian V S Hill; Fergal Hill; Simon J Draper","The Jenner Institute, University of Oxford, Oxford, United Kingdom; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Rockville, Maryland, United States of America; Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Imaxio SA, Lyon, France","Conceived and designed the experiments: EKF AVSH FH SJD. Performed the experiments: EKF SdC DL CAL SJD. Analyzed the data: EKF SdC MGC CAL SJD. Contributed reagents/materials/analysis tools: SB ALG RJP FH. Wrote the paper: EKF SJD.","The authors have read the journals policy and have the following conflicts: ALG, AVSH, FH and SJD are named inventors on US 12/595 574 and UK PCT/GB2008/01262, US 12/595 351 and UK PCT/GB2008/01271 patent applications covering malaria vectored vaccines and immunization regimes. FH is an employee of Imaxio SA which owns rights to and is developing the C4 bp adjuvant technology. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Emily K Forbes","EKF",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
